Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?

Bibliographic Details
Main Author: Andrew Z. Wang
Format: Article
Language:English
Published: Elsevier 2014-12-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396414000425
_version_ 1811318338645655552
author Andrew Z. Wang
author_facet Andrew Z. Wang
author_sort Andrew Z. Wang
collection DOAJ
first_indexed 2024-04-13T12:24:47Z
format Article
id doaj.art-f3d465807a1046d98ba5c7f7f4af9ad9
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-04-13T12:24:47Z
publishDate 2014-12-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-f3d465807a1046d98ba5c7f7f4af9ad92022-12-22T02:47:04ZengElsevierEBioMedicine2352-39642014-12-011210110210.1016/j.ebiom.2014.11.013Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?Andrew Z. Wanghttp://www.sciencedirect.com/science/article/pii/S2352396414000425
spellingShingle Andrew Z. Wang
Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?
EBioMedicine
title Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?
title_full Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?
title_fullStr Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?
title_full_unstemmed Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?
title_short Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?
title_sort nanoparticle formulations of sirna the next generation of targeted therapy for lymphomas and leukemias
url http://www.sciencedirect.com/science/article/pii/S2352396414000425
work_keys_str_mv AT andrewzwang nanoparticleformulationsofsirnathenextgenerationoftargetedtherapyforlymphomasandleukemias